The majority of people with type
1
diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the
GOLD
randomized trial (
GOLD‐5
)
Diabetes, Obesity and Metabolism（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要